Clinical Trial Update: An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular Hypertension

View source ↗

Summary

The registry entry indicates the observational study evaluating the ETX-4143 device for ocular hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension

Drugs mentioned

• ETX-4143 device

Snippet

Sponsor: EyeCool Therapeutics, Inc. | Conditions: Ocular Hypertension | Status: WITHDRAWN